The following IP guidance note provides comprehensive and up to date legal information covering:
This Practice Note discusses some of the key considerations and implications for IP practitioners during the coronavirus (COVID-19) pandemic. It also includes a table containing an archive of news items on coronavirus and coronavirus developments that relate to IP.
For a discussion about the impact of the pandemic on IP strategy and practice, see News Analysis: Coronavirus (COVID-19)—the impact on IP strategy and practice.
In light of the coronavirus pandemic and associated guidance on social distancing, offices were closed and some postal services suspended. In response to such measures, the UK Intellectual Property Office (IPO), World Intellectual Property Office (WIPO), European Patent Office (EPO) and EU Intellectual Property Office (EUIPO) announced changes to various IP deadlines and procedures. These announcements are tracked in the IP coronavirus tracker below and the IPO, WIPO, EPO and EUIPO have created dedicated and maintained coronavirus pages. Due to the fast-paced nature of the coronavirus crisis, it is essential to check these sites before undertaking any IP procedures during this time. For more information on:
IPO tribunals and hearings, see: Alterations to our services—tribunals and hearings
IPO patent procedures, see: Alterations to services—patents
IPO trade marks and designs procedures, see: Alterations to services—trade marks and designs
general information relating to IP service at WIPO, see: Covid-19 Update: WIPO’s IP Services
**Trials are provided to all LexisPSL and LexisLibrary content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
0330 161 1234
To view our latest legal guidance content,sign-in to Lexis®PSL or register for a free trial.